We find the best cells. So much discovery in cellular therapy, biopharmaceuticals and genomics depends on precise, time-consuming, cell-by-cell manipulation.
Location: United States, California, Emeryville
Employees: 201-500
Total raised: $185M
Valuation: $3.9B
Founded date: 2011
Investors 10
Funding Rounds 2
| Date | Series | Amount | Investors |
| 15.10.2018 | - | $95M | - |
| 29.09.2015 | - | $90M | - |
Mentions in press and media 16
| Date | Title | Description |
| 18.02.2025 | California’s H5N1 Emergency Declaration Highlights Need for an Urgent National Response to Avian Flu | Shaun Holt, CEO of Alveo Technologies The H5N1 virus is spreading so rapidly among cattle in California that Gavin Newsom declared a state of emergency. Sick cattle not only produce less milk, but their milk is also infected with the virus,... |
| 13.02.2023 | Berkeley Lights to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 | EMERYVILLE, Calif., Feb. 13, 2023 /PRNewswire/ -- Berkeley Lights, Inc. BLI, a life sciences tools company, today announced that the Company will be reporting financial results for the fourth quarter and full year 2022 after market on Thurs... |
| 22.06.2022 | Meet Nicholas Brathwaite, Managing Partner at Celesta Capital | Celesta Capital invests in deep tech companies, with a focus on hardware, out of a $400M fund Venture capital used to be a cottage industry, with very few investing in tomorrow's products and services. Oh, how times have changed! While ther... |
| 06.06.2022 | Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities | EMERYVILLE, Calif. & ALBANY, N.Y.–(BUSINESS WIRE)–June 6, 2022– Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Curia, formerly AMRI, a leading contract research, development and manufacturing organization (CD... |
| 20.12.2021 | Prellis Biologics 3D bioprints lymph node to unlock antibody discovery at pace | Biotechnology firm Prellis Biologics has announced the closure of a $14.5 million Series B funding round alongside the creation of a novel antibody discovery platform. Effectively a functioning immune system in a dish, the firm’s platform i... |
| 25.05.2021 | Meet The Collaboration Solving Some Of Antibody Discovery’s Toughest Problems | Berkeley LightsBerkeley Lights |
| 11.09.2020 | Bioeconomy Powerhouse Berkeley Lights Nearly Triples Since IPO, Now Valued At $3.9 Billion | How small groups of live cells can be plucked like needles from a haystack: An assay performed by ... [+] the University of Queensland on a Berkeley Lights' NanoPen™ for their COVID-19 treatment research. Berkeley Lights, Inc. |
| 09.09.2020 | Synthetic Biology Startups Raised $3 Billion In The First Half Of 2020 | (Getty Images/Luis Alvarez) |
| 30.06.2020 | “Berkeley Lights Files for $100M IPO” | - |
| 29.06.2020 | The biotech IPO boom is becoming ‘historic’ as four more throw their hats in | Four more US biotechs filed to go public Friday as yet more companies clamber to get through a yawning IPO window and onto a market that’s signaled its willingness to reward nearly any new drugmaker. The new entrants are le... |
Show more